U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700758) titled 'A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)' on July 08.
Brief Summary: Researchers are looking for new ways to treat adolescents with locally advanced, unresectable, or metastatic solid tumors. Participants were enrolled into pheochromocytoma/paraganglioma (PPGL), wild type gastrointestinal stromal tumor (wtGIST), and Von Hippel-Lindau (VHL) disease-associated localized tumors cohorts:
* PPGL are rare cancers that start in cells that make hormones in the adrenal glands
* wtGIST is a less common type of cancer that starts in the digestive tract. Wild type means it does not have ce...